|
Scisparc Ltd. (SPRC) DCF Valoración
IL | Healthcare | Biotechnology | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
SciSparc Ltd. (SPRC) Bundle
¿Busca determinar el valor intrínseco de Scisparc Ltd.? Nuestra calculadora SPRC DCF integra datos del mundo real con extensas características de personalización, lo que le permite refinar sus pronósticos y mejorar sus estrategias de inversión.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | .5 | .6 | 1.1 | 1.3 | 2.9 | 4.5 | 7.2 | 11.3 | 17.8 | 28.1 |
Revenue Growth, % | 0 | 10.44 | 94.36 | 26.01 | 113.73 | 57.7 | 57.7 | 57.7 | 57.7 | 57.7 |
EBITDA | -3.7 | -2.4 | -5.7 | -2.2 | -5.3 | -4.5 | -7.2 | -11.3 | -17.8 | -28.1 |
EBITDA, % | -749.4 | -434 | -537.32 | -166.74 | -184.58 | -100 | -100 | -100 | -100 | -100 |
Depreciation | .2 | .2 | .0 | .2 | .5 | .9 | 1.5 | 2.3 | 3.6 | 5.7 |
Depreciation, % | 35.94 | 29.82 | 3.09 | 13.88 | 18.69 | 20.28 | 20.28 | 20.28 | 20.28 | 20.28 |
EBIT | -3.9 | -2.6 | -5.8 | -2.4 | -5.9 | -4.5 | -7.2 | -11.3 | -17.8 | -28.1 |
EBIT, % | -785.34 | -463.82 | -540.41 | -180.62 | -203.27 | -100 | -100 | -100 | -100 | -100 |
Total Cash | .9 | 1.9 | 6.9 | 3.6 | 5.1 | 4.5 | 7.2 | 11.3 | 17.8 | 28.1 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | .1 | .3 | 2.6 | .2 | .3 | 1.7 | 2.7 | 4.2 | 6.7 | 10.5 |
Account Receivables, % | 12.85 | 52 | 239.1 | 12.47 | 9.97 | 37.46 | 37.46 | 37.46 | 37.46 | 37.46 |
Inventories | .0 | .0 | .0 | .7 | .7 | .8 | 1.2 | 1.9 | 3.0 | 4.7 |
Inventories, % | 2.01 | 1.82 | 4.21 | 49.59 | 25.77 | 16.68 | 16.68 | 16.68 | 16.68 | 16.68 |
Accounts Payable | .3 | .3 | .4 | .3 | .3 | 1.7 | 2.7 | 4.3 | 6.8 | 10.7 |
Accounts Payable, % | 68.07 | 50.36 | 41.25 | 22.12 | 9.17 | 38.2 | 38.2 | 38.2 | 38.2 | 38.2 |
Capital Expenditure | .0 | .0 | .0 | -4.9 | .0 | -.9 | -1.5 | -2.3 | -3.7 | -5.8 |
Capital Expenditure, % | -0.2008 | 0 | -3.27 | -361.47 | 0 | -20.69 | -20.69 | -20.69 | -20.69 | -20.69 |
Tax Rate, % | 12.61 | 12.61 | 12.61 | 12.61 | 12.61 | 12.61 | 12.61 | 12.61 | 12.61 | 12.61 |
EBITAT | -4.7 | -2.5 | -5.8 | -2.4 | -5.1 | -4.4 | -7.0 | -11.0 | -17.3 | -27.3 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -4.2 | -2.7 | -7.9 | -5.5 | -4.8 | -4.4 | -7.4 | -11.7 | -18.4 | -29.1 |
WACC, % | 7.86 | 7.85 | 7.86 | 7.86 | 7.69 | 7.83 | 7.83 | 7.83 | 7.83 | 7.83 |
PV UFCF | ||||||||||
SUM PV UFCF | -53.4 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | -30 | |||||||||
Terminal Value | -509 | |||||||||
Present Terminal Value | -349 | |||||||||
Enterprise Value | -403 | |||||||||
Net Debt | -2 | |||||||||
Equity Value | -401 | |||||||||
Diluted Shares Outstanding, MM | 0 | |||||||||
Equity Value Per Share | -982.05 |
What You Will Get
- Real SPRC Financial Data: Pre-filled with SciSparc Ltd.’s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See SciSparc Ltd.’s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Comprehensive SPRC Data: Pre-loaded with SciSparc Ltd.'s historical performance metrics and future growth estimates.
- Highly Customizable Variables: Modify parameters such as revenue growth, profit margins, discount rates, tax considerations, and capital investments.
- Interactive Valuation Framework: Automatic recalculations of Net Present Value (NPV) and intrinsic worth based on your adjustments.
- Multiple Scenario Analysis: Develop various forecasting scenarios to evaluate different valuation results.
- Intuitive User Interface: Clean, organized, and suitable for both seasoned professionals and newcomers.
How It Works
- Download: Obtain the pre-formatted Excel file containing SciSparc Ltd.'s (SPRC) financial data.
- Customize: Tailor forecasts such as revenue growth, EBITDA %, and WACC to your preferences.
- Update Automatically: Enjoy real-time updates for intrinsic value and NPV calculations.
- Test Scenarios: Develop various projections and instantly compare the results.
- Make Decisions: Leverage the valuation outcomes to inform your investment approach.
Why Choose SciSparc Ltd. (SPRC) Calculator?
- All-in-One Solution: Combines DCF, WACC, and financial ratio assessments for comprehensive analysis.
- Flexible Parameters: Modify highlighted cells to explore different financial scenarios.
- In-Depth Analysis: Automatically computes SciSparc’s intrinsic value and Net Present Value.
- Integrated Data: Features historical and projected data for reliable analysis.
- Expert-Level Tool: Perfect for financial analysts, investors, and business advisors.
Who Should Use SciSparc Ltd. (SPRC)?
- Investors: Gain insights into innovative biotech solutions and make informed investment choices.
- Financial Analysts: Utilize comprehensive data to streamline analysis of the biotech sector.
- Consultants: Easily customize reports and presentations for clients interested in biotech opportunities.
- Biotech Enthusiasts: Enhance your knowledge of cutting-edge treatments and technologies through real-world applications.
- Educators and Students: Leverage it as a valuable resource for understanding the biotech industry's dynamics.
What the Template Contains
- Pre-Filled Data: Includes SciSparc Ltd.'s historical financials and forecasts.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Analyze SciSparc Ltd.'s profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
- Clear Dashboard: Charts and tables summarizing key valuation results.